Max Rosett

Max Rosett

Interim Chief Financial Officer And EVP, Operations @ Immunome

About Max Rosett

Max Rosett Title

Max Rosett is the Interim Chief Financial Officer and Executive Vice President of Operations at Morphimmune. He joined Morphimmune in 2022 as the Acting Chief Operating Officer. His roles involve overseeing financial operations and contributing to the strategic planning and operational execution of the company.

Max Rosett's Experience

Max Rosett has over a decade of experience in data-driven roles. He has an extensive background that spans multiple industries, including pharmaceuticals, technology, and business operations. His previous positions include working as a Principal at Research Bridge Partners, engineer at Google, and business operations role at a Silicon Valley startup. Rosett's experience includes leading Morphimmune's Series A at Research Bridge Partners.

Max Rosett Education

Max Rosett holds a Master of Science degree from Georgia Tech and a Bachelor of Arts in mathematics from Yale University. His education in advanced mathematics and engineering provides a solid foundation for his data-driven and analytical approach in various roles throughout his career.

Max Rosett Background in Consulting

Max Rosett began his career at the Boston Consulting Group. During his time with BCG, he served clients in the pharmaceutical industry, leveraging his analytical skills and industry knowledge to deliver strategic insights and solutions. His role at BCG laid the groundwork for his future positions in business and operations.

People similar to Max Rosett